Apellis Pharmaceuticals Inc

NASDAQ:APLS   2:35:08 PM EDT
44.92
+0.11 (+0.24%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)4.78B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$21.86 Million
Adjusted EPS-$1.29
See more estimates
10-Day MA$42.68
50-Day MA$47.69
200-Day MA$44.28
See more pivots

Apellis Pharmaceuticals Inc Stock, NASDAQ:APLS

100 5th Avenue, Suite A, Waltham, Massachusetts 02451-8703
United States of America
Phone: +1.617.977.5700
Number of Employees: 476

Description

Apellis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which develops novel therapeutic and complement immunotherapies for the treatment of complement-dependent autoimmune and inflammatory diseases through APL-2 product. The company was founded by Candace Rose Depp, Pascal Deschatelets, Cedric Francois, Alec Machiels on September 25, 2009 and is headquartered in Waltham, MA.